These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21276053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reactive perforating collagenosis and Down's syndrome.
    De Berker DA, Wilson CL, Millard PR.
    Br J Dermatol; 1992 Jan; 126(1):71-3. PubMed ID: 1531611
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquired reactive perforating collagenosis in an insulin dependent diabetes mellitus patient.
    Khan Y, Swain JP.
    J Indian Med Assoc; 2009 Nov; 107(11):825-6. PubMed ID: 20469788
    [Abstract] [Full Text] [Related]

  • 7. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.
    Huseynova L, Akdogan N, Gököz Ö, Evans SE.
    An Bras Dermatol; 2020 Nov; 95(3):336-339. PubMed ID: 32359703
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reactive perforating collagenosis in a setting of double disaster: acquired immunodeficiency syndrome and end-stage renal disease.
    Bank DE, Cohen PR, Kohn SR.
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):371-4. PubMed ID: 2754070
    [Abstract] [Full Text] [Related]

  • 10. A case of acquired reactive perforating collagenosis.
    Reid J, Almond L, Matthewman N, Stringer H, Francis N, Al Abadie M.
    Australas J Dermatol; 2018 Feb; 59(1):e75-e76. PubMed ID: 28636209
    [No Abstract] [Full Text] [Related]

  • 11. Acquired reactive perforating collagenosis: report of a case and review of the literature.
    Mahanupab P, Chiewchanvit S.
    J Med Assoc Thai; 2002 Sep; 85(9):1019-23. PubMed ID: 12450082
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of acquired reactive perforating collagenosis.
    Tsuboi H, Katsuoka K.
    J Dermatol; 2007 Sep; 34(9):640-4. PubMed ID: 17727367
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cutaneous mucormycosis secondary to acquired reactive perforating collagenosis.
    Weiss SC, Moschella SL, Kwan T, Craven DE.
    Cutis; 2003 Aug; 72(2):119-23. PubMed ID: 12953934
    [Abstract] [Full Text] [Related]

  • 16. Acquired reactive perforating collagenosis associated with papillary thyroid carcinoma: a paraneoplastic phenomenon?
    Yazdi S, Saadat P, Young S, Hamidi R, Vadmal MS.
    Clin Exp Dermatol; 2010 Mar; 35(2):152-5. PubMed ID: 19438550
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab.
    Yamada K, Baba A, Kanekura T.
    J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):e750-e752. PubMed ID: 38358063
    [No Abstract] [Full Text] [Related]

  • 19. Acquired reactive perforating collagenosis: unilateral umbilicated papules along the lesions of herpes zoster.
    Bang SW, Kim YK, Whang KU.
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):778-9. PubMed ID: 9146541
    [No Abstract] [Full Text] [Related]

  • 20. Successful treatment of acquired reactive perforating collagenosis with topical benzoyl peroxide: A possible therapeutic action underlying structural and metabolic turnover.
    Miyanaga M, Oyama N, Sakai Y, Imamura Y, Hasegawa M.
    J Dermatol; 2020 Jan; 47(1):e12-e14. PubMed ID: 31599039
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.